Home / TIL : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TIL make money? Does TIL have pricing power? What's the Earnings Whisper? Will TIL profit more as the business scales? What is TIL's management track record? Is TIL's current price justified?

Instil Bio, Inc.

$7.38 -$3.89 (-34.52%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$7.36

Day Range

$7.32$7.67

Year Range

$5.67$25.89

Market Cap

50.05M

AVG Volume

19.03K

Trailing/Forward PE

-1.65/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

2026-11-16

Primary Exchange

NASDAQ

Revenue (USD)

TIL Revenue (USD) by year
Period	Revenue (USD)
2025	0
2024	0
2023	0
2022	0
2021	0
2020	138K

Net Income (USD)

TIL Net Income (USD) by year
Period	Net Income (USD)
2025	-71.37M
2024	-74.14M
2023	-156.09M
2022	-223.18M
2021	-156.79M
2020	-37.74M

Operating Income (USD)

TIL Operating Income (USD) by year
Period	Operating Income (USD)
2025	-78.58M
2024	-68.92M
2023	-159M
2022	-226.46M
2021	-155.56M
2020	-33.64M

EBITDA (USD)

TIL EBITDA (USD) by year
Period	EBITDA (USD)
2025	-65.77M
2024	-62.2M
2023	-146.37M
2022	-217.38M
2021	-153.24M
2020	-32.72M

Cash Flows (USD)

TIL Cash Flows (USD) by year
Period	Cash Flows (USD)
2025	-36.62M
2024	-55.7M
2023	-102.69M
2022	-264.75M
2021	-179.97M
2020	-80.43M

EPS (USD)

TIL EPS (USD) by year
Period	EPS (USD)
2025	-10.78
2024	-11.39
2023	-23.89
2022	-9.6
2021	-1.69
2020	-0.83

Expenses (USD)

TIL Expenses (USD) by year
Period	Expenses (USD)
2025	51.96M
2024	54.31M
2023	106.78M
2022	287.88M
2021	216.39M
2020	84.6M

Cash & Debt (USD)

TIL Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2025	76.13M
2024	113.31M
2023	150.36M
2022	260.92M
2021	454.1M
2020	241.71M

Debt ratios

TIL Debt ratios by year
Period	Debt ratios
2025	-0.02
2024	0.05
2023	0.12

Margins

TIL Margins by year
Period	Margins
2020	100%

Return on Capital

TIL Return on Capital by year
Period	Return on Capital
2025	-62.68%
2024	-43.75%
2023	-69.12%
2022	-61.38%
2021	-28.24%
2020	-12.91%

Shares Outstanding

TIL Shares Outstanding by year
Period	Shares Outstanding
2025	6.78M
2024	6.53M
2023	6.5M
2022	6.49M
2021	6.45M
2020	6.41M

Book Value Per Share (USD)

TIL Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2025	16.79
2024	25.96
2023	34.72
2022	55.99
2021	86.11
2020	45.61

Total Assets (USD)

TIL Total Assets (USD) by year
Period	Total Assets (USD)
2025	203.52M
2024	263.57M
2023	325.63M
2022	482.13M
2021	609.98M
2020	319.01M

Employee Count

TIL Employee Count by year
Period	Employee Count
2025	17
2024	14
2023	49
2022	192
2021	412

Free Cash Flow Yield

TIL Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-47.18%
Sep 26	-45.93%
Aug 26	-45.93%
Aug 26	-45.93%
Aug 26	-47.18%
Aug 26	-67.18%
Jul 26	-69.92%
Jul 26	-69.82%
Jul 26	-67.09%
Jul 26	-64.65%
Jul 26	-64.4%
Jun 26	-67%
Jun 26	-66.37%
Jun 26	-62.85%
Jun 26	-61.69%
May 26	-61.69%
May 26	-60.86%
May 26	-61.69%
May 26	-66.17%
May 26	-68.35%
Apr 26	-66.99%
Apr 26	-60.8%
Apr 26	-66.58%
Apr 26	-67.24%
Mar 26	-69.31%
Mar 26	-69.41%
Mar 26	-71.84%
Mar 26	-66.9%
Feb 26	-66.68%
Feb 26	-64.78%
Feb 26	-74.27%
Feb 26	-76.47%
Jan 26	-84.05%
Jan 26	-83.11%
Jan 26	-83.94%
Jan 26	-83.23%
Jan 26	-52.66%
Dec 25	-52.47%
Dec 25	-52.66%
Dec 25	-54.74%
Dec 25	-54.34%
Nov 25	-46.51%
Nov 25	-45.16%
Nov 25	-41.15%
Nov 25	-49.9%
Oct 25	-42.69%
Oct 25	-38.82%
Oct 25	-39.45%
Oct 25	-39.16%
Oct 25	-41.6%
Sep 25	-44.48%
Sep 25	-37.78%
Sep 25	-31.25%
Sep 25	-23.91%
Aug 25	-27.89%
Aug 25	-27.9%
Aug 25	-27.05%
Aug 25	-24.88%
Aug 25	-31.33%
Jul 25	-21.98%
Jul 25	-26.69%
Jul 25	-28.44%
Jul 25	-25.33%
Jun 25	-30.32%
Jun 25	-25.14%
Jun 25	-20.35%
Jun 25	-21.18%
May 25	-25.84%
May 25	-33.13%
May 25	-47.61%
May 25	-64.51%
May 25	-58.94%
Apr 25	-66.78%
Apr 25	-55.2%
Apr 25	-56.78%
Apr 25	-58.42%
Mar 25	-47.2%
Mar 25	-47.71%
Mar 25	-42.93%
Mar 25	-46.61%
Feb 25	-44.79%
Feb 25	-40.7%
Feb 25	-39.12%
Feb 25	-43.22%
Jan 25	-40.44%
Jan 25	-38.41%
Jan 25	-42.93%
Jan 25	-45.35%
Jan 25	-43.68%
Dec 24	-44.9%
Dec 24	-43.68%
Dec 24	-40.98%
Dec 24	-32.42%
Nov 24	-33.45%
Nov 24	-34.43%
Nov 24	-33.97%
Nov 24	-28.93%
Nov 24	-31%
Oct 24	-28.72%
Oct 24	-23.82%

Price to Sales

TIL Price to Sales by year
Period	Price to Sales
Nov 21	51200.15
Nov 21	54072.11
Oct 21	50432.64
Oct 21	45084.85
Oct 21	44366.86
Oct 21	44441.13
Oct 21	47337.85
Sep 21	57166.9
Sep 21	48922.39
Sep 21	46223.73
Sep 21	53180.81
Aug 21	49491.83
Aug 21	41371.11
Aug 21	40925.46
Aug 21	23433.99
Jul 21	20612.6
Jul 21	26597.78
Jul 21	25885.58
Jul 21	27364.76
Jul 21	27501.72
Jun 21	26022.55
Jun 21	24680.33
Jun 21	23283.33
Jun 21	21311.1
May 21	24379.02
May 21	25214.48
May 21	24652.94
May 21	17605.96
Apr 21	19073.89
Apr 21	15459.79
Apr 21	17652.41
Apr 21	20467.5
Apr 21	22009.77
Mar 21	25140.75
Mar 21	24564.72

Price to Book

TIL Price to Book by year
Period	Price to Book
Sep 26	0.47
Sep 26	0.48
Aug 26	0.48
Aug 26	0.48
Aug 26	0.47
Aug 26	0.45
Jul 26	0.44
Jul 26	0.44
Jul 26	0.45
Jul 26	0.47
Jul 26	0.47
Jun 26	0.46
Jun 26	0.46
Jun 26	0.49
Jun 26	0.49
May 26	0.49
May 26	0.5
May 26	0.49
May 26	0.49
May 26	0.47
Apr 26	0.48
Apr 26	0.53
Apr 26	0.48
Apr 26	0.48
Mar 26	0.46
Mar 26	0.48
Mar 26	0.46
Mar 26	0.5
Feb 26	0.5
Feb 26	0.51
Feb 26	0.45
Feb 26	0.44
Jan 26	0.4
Jan 26	0.4
Jan 26	0.4
Jan 26	0.4
Jan 26	0.63
Dec 25	0.63
Dec 25	0.63
Dec 25	0.61
Dec 25	0.61
Nov 25	0.72
Nov 25	0.74
Nov 25	0.81
Nov 25	0.76
Oct 25	0.88
Oct 25	0.97
Oct 25	0.96
Oct 25	0.96
Oct 25	0.91
Sep 25	0.85
Sep 25	1
Sep 25	1.21
Sep 25	1.58
Aug 25	1.35
Aug 25	1.35
Aug 25	1.39
Aug 25	1.26
Aug 25	1
Jul 25	1.43
Jul 25	1.18
Jul 25	1.1
Jul 25	1.24
Jun 25	1.04
Jun 25	1.25
Jun 25	1.54
Jun 25	1.48
May 25	1.21
May 25	0.95
May 25	0.66
May 25	0.51
May 25	0.56
Apr 25	0.49
Apr 25	0.6
Apr 25	0.58
Apr 25	0.56
Mar 25	0.7
Mar 25	0.69
Mar 25	0.77
Mar 25	0.71
Feb 25	0.74
Feb 25	0.82
Feb 25	0.85
Feb 25	0.77
Jan 25	0.82
Jan 25	0.86
Jan 25	0.77
Jan 25	0.73
Jan 25	0.76
Dec 24	0.74
Dec 24	0.76
Dec 24	0.81
Dec 24	1.02
Nov 24	0.99
Nov 24	0.96
Nov 24	0.98
Nov 24	1.03
Nov 24	0.96
Oct 24	1.04
Oct 24	1.25

No video analysis for this stock yet. Request one from our team.

News: TIL

zacks.com · 26 Aug 2026

5 Biotech Stocks Worth Adding to Your Portfolio Now

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry despite the uncertain macroeconomic environment. A strong portfolio and solid pipeline progress position HALO, RGEN, IOVA, ARQT and PGEN in this volatile sector.

globenewswire.com · 13 Aug 2026

Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update

DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its second quarter 2026 financial results and provided a corporate update. Recent Highlights: Instil is evaluating potential acquisitions, in-licensing and related opportunities that may provide access to promising novel therapeutic candidates.

gurufocus.com · 3 Aug 2026

Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million

Obsidian Therapeutics, Inc. (âObsidianâ) (Nasdaq: OBX), a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop

seekingalpha.com · 16 Jul 2026

Iovance: The Worst May Be Behind This TIL Pioneer (Upgrading To Buy)

Iovance Biotherapeutics is showing steady operational and financial progress, supporting a speculative Buy rating upgrade. Q1 revenue reached $71.4M, with Amtagvi generating $60M; the sequential dip was attributed to one-off events, not demand weakness. Gross margin was impacted by temporary costs but is expected to improve to 50%+ as internal manufacturing scales and opex reductions take effect.